October 2021 – schizophrenia

Oct 31 2021

Asenapine Transdermal Patches Effective for Reducing Hostility in Patients With Schizophrenia

by Clinical Editor

No Comments

Investigators report the results of a post hoc analysis of a trial investigating the effectiveness of HP-3070 on hostility in patients with schizophrenia.

Oct 31 2021

Uncategorized

Psychosocial interventions can help prevent schizophrenia relapse

by Clinical Editor

No Comments

(HealthDay)—Psychosocial and psychological interventions are effective for relapse prevention in schizophrenia, according to a review published online Oct. 12 in The Lancet Psychiatry.

Oct 31 2021

Uncategorized

Digital Therapeutic Engagement May Improve Schizophrenia Symptoms

by Clinical Editor

No Comments

Researchers reported the findings of a post-hoc analysis conducted to determine the impact of engagement with a digital medicine system on symptom severity in patients with schizophrenia or bipolar I...

Oct 31 2021

Uncategorized

He was diagnosed with schizophrenia in ICE custody. A decade later, he’s stuck in the legal system

by Clinical Editor

No Comments

Detention often is the first line of treatment for people who don’t have access to care, and then many end up stuck in a complex legal system.

Oct 31 2021

Uncategorized

A new treatment for schizophrenia on Coast Live

by Clinical Editor

No Comments

HAMPTON ROADS, Va. – Schizophrenia is a complex and chronic brain disorder affecting approximately 2.8 million adults in the U.S. alone. Adult patients with schizophrenia can struggle to control their...

Oct 30 2021

Uncategorized

Psychosocial interventions can help prevent schizophrenia relapse

by Clinical Editor

No Comments

(HealthDay)—Psychosocial and psychological interventions are effective for relapse prevention in schizophrenia, according to a review published online Oct. 12 in The Lancet Psychiatry.

Oct 30 2021

Uncategorized

A new treatment for schizophrenia on Coast Live

by Clinical Editor

No Comments

Oct 30 2021

Uncategorized

Tardive Dyskinesia in Schizophrenia: A Genome-Wide Association Study

by Clinical Editor

No Comments

Investigators recently analyzed 1406 genetic samples from people with schizophrenia of East Asian, European, and African-American ancestry. Three genes previously linked to amyotrophic lateral …

Oct 30 2021

Uncategorized

Genetic Risk for Schizophrenia Not Associated With Neuropsychiatric Features in Childhood-Onset SLE

by Clinical Editor

No Comments

Researchers studied the association between schizophrenia genetic susceptibility loci and neuropsychiatric features in childhood-onset systemic lupus erythematosus.

Oct 30 2021

Uncategorized

Continual Inventions To Accelerate The Schizophrenia Treatment Market

by Clinical Editor

No Comments

The global Schizophrenia Treatment Market is expected to stimulate at a good rate In Upcoming Years Virtual consultations are amongst the ongoing trends They mitigate the spreading of contagious …

Month: October 2021